18.01.2005 23:28:00

CORRECTING AND REPLACING Dade Behring and Inpeco Sign Agreement for Lo

CORRECTING AND REPLACING Dade Behring and Inpeco Sign Agreement for Long-Term Partnership in Lab Automation; Assures access to new automation technologies


    Business Editors
    CORRECTION...by Business Wire

    DEERFIELD, Ill.--(BUSINESS WIRE)--Jan. 18, 2005--In BW6049 issued Jan. 18, 2005: In the original version of this release, BW6028 issued at 14:23 ET today, Business Wire inadvertently dropped the letter "n" in the first usage of the word "automation."

    The corrected release reads:

    DADE BEHRING AND INPECO SIGN AGREEMENT FOR LONG-TERM PARTNERSHIP IN LAB AUTOMATION; ASSURES ACCESS TO NEW AUTOMATION TECHNOLOGIES

    Dade Behring (NASDAQ:DADE), the world's largest company solely dedicated to diagnostics, and Inpeco, a global supplier of automation technology solutions, announced today that they have signed a memo of understanding designed to solidify their long-term partnership in laboratory automation. Under this agreement, Dade Behring will have immediate access to new automation technologies developed by Inpeco, thus ensuring a steady stream of leading edge capabilities for Dade Behring's automation solutions, including the StreamLAB(R) Analytical Workcell.
    "This is the type of intelligent partnership that leverages our strong instrument capabilities and the core competencies of our selected automation partners," said Jim Reid-Anderson, Chairman, President and CEO, Dade Behring. "It is an arrangement that reflects our focus on the future of automation technology and our flexible approach to automation. We are proud of our automation offering and the broad-based solutions we provide, which are customized to meet the real needs of our customers." "StreamLAB is a key element of our automation strategy, and global placements of StreamLAB were at an all time high in 2004," said Rick Lee, Corporate Vice President, Global Marketing at Dade Behring. "Interest in our StreamLAB solution continues to increase globally. This partnership supports our unique approach to automation, which is focused on creating individualized solutions based on customer needs and requirements."
    "As a leading technology player in the fast growing clinical automation market, we are dedicated to this continued partnership with Dade Behring, a global leader in the clinical diagnostic market," said Andrea Pedrazzini, President of Inpeco. "Our business strategy focuses on key technologies in the IVD industry that benefit from expertise in automation. Having already worked closely with Dade Behring, to develop one of their current automation solutions, StreamLAB, we are certain this automation partnership will be unparalleled by any other in the marketplace."

    About Inpeco

    Inpeco started its activity in automation technology solutions in 1990, and since then it has been working with most of the major companies and institutions in the IVD, pharmaceutical and life sciences sectors. The company's strategy has been driven, since the very beginning, by final customer needs. Product quality and innovation are major goals. Additional company information is available on the internet at www.inpeco.com.

    About Dade Behring

    With 2003 revenues of over $1.4 billion, Dade Behring is the world's largest company dedicated solely to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of labs, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the internet at www.dadebehring.com.

--30--CE/cg*

CONTACT: Dade Behring Pattie Overstreet-Miller, 847-267-5426 or Deirdra Dougherty, 302-631-6872 or Inpeco G. Andrea Pedrazzini, 39-02-2138-438

KEYWORD: ILLINOIS INDUSTRY KEYWORD: BANKING MEDICAL DEVICES NETWORKING MARKETING AGREEMENTS SOURCE: Dade Behring

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Dade Behring Holdings Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Dade Behring Holdings Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 478,88 -0,06%